Home / Health / Brain Implant Trial Gives Epilepsy Patients New Hope
Brain Implant Trial Gives Epilepsy Patients New Hope
16 Nov
Summary
- 22-year-old patient's brain implant reveals unknown seizures
- Doctors gain unprecedented remote monitoring capabilities
- Implant trial aims to determine its effectiveness and cost-benefit
As of November 16th, 2025, a groundbreaking brain implant trial in the UK is giving new hope to epilepsy patients and their families. Adam Atkinson, a 22-year-old from Whitehaven, Cumbria, had the implant installed two months ago at the Freeman Hospital in Newcastle as part of the six-month study.
The device has already provided Atkinson's doctors with invaluable insights into his seizures, which he has experienced regularly since developing a rare brain disease called seronegative autoimmune encephalitis at age 15. Atkinson's mother, Vicki Brown, says the implant has revealed aspects of her son's seizures that were previously unknown, including the fact that he experiences regular seizures during his sleep.
According to Dr. Rhys Thomas, who is leading the trial in northeast England and Cumbria, the implant gives doctors an "unprecedented opportunity" to monitor patients remotely, a significant improvement over the current standard of having patients track their own episodes in a diary. The trial aims to determine whether the implant is a worthwhile investment that can lead to more targeted treatment for individuals.
As Atkinson adjusts to the constant presence of the implant in his head, his mother expresses gratitude for the glimmer of hope the trial has provided. "This just gives you a little bit of hope," she says, after years of feeling like there was nothing much they could do.
